Embryonic Stem Cells To Treat Macular Degeneration Trial Approved By FDA
The first trial has been approved by the FDA using retinal cells derived from human embryonic stem cells to treat patients with SMD (Stargardt's Macula Dystrophy), a common form of macular degeneration that affects young people...